- $67.94m
- $118.00m
- $81.67m
Akoya Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Akoya Biosciences Inc Files For Mixed Shelf Of Up To $150 Million - SEC Filing
Brief: Akoya Reports Third Quarter Results, Raises Full Year 2022 Revenue Guidance
Akoya Biosciences Inc expected to post a loss of 44 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Analog Devices, Bath & Body Works, Synopsys
U.S. RESEARCH ROUNDUP- Avalara, Global Blood Therapeutics, Tyson Foods
Akoya Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Akoya Biosciences Q2 Revenue Up 37% To $17.9 Mln
Brief: Akoya Biosciences To Partner With Acrivon Therapeutics For The Clinical Development Of Acrivon’s Proprietary Oncosignature Test Into A Companion Diagnostic
U.S. RESEARCH ROUNDUP-Alexandria Real Estate Equities, Beacon Roofing Supply, Snowflake
Brief: Akoya Biosciences Entered Into Amendment No. 2 To Credit & Security Agreement To Provide Additional Tranche Of Non-Dilutive Funding
Brief: Akoya Reports First Quarter 2022 Operating Results
Akoya Biosciences Inc reports results for the quarter ended in March - Earnings Summary
NASDAQ RESUMED AT 03:08 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:05 PM
Akoya Biosciences Inc expected to post a loss of 39 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Joann, Park Ohio Holdings
Akoya Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Akoya Biosciences Inc Reports Fourth Quarter And Full Year 2021 Operating Results